IP Library › Assignment 064405/0496
Patent Assignment
Reel/Frame 064405/0496

Assignment of Assignor's Interest

Recorded: 2023-07-27 Pages: 12
Assignor
MABVAX THERAPEUTICS, INC.
Executed: 2019-05-07
Assignee
BIONTECH RESEARCH AND DEVELOPMENT, INC.
228 E. 45TH STREET, SUITE 9E, NEW YORK, NEW YORK, 10017
Covered Property (1)
Human Monoclonal Antibodies to Ganglioside GD2
Application: 17/131,713 →
Publication: US 2021/0189000
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 27, 2023
From: SCHOLZ, WOLFGANG; SAWADA, RITSUKO
To: MABVAX THERAPEUTICS, INC.
Reel/Frame 064405/0462 →
Assignment of Assignor's Interest Jul 27, 2023
From: BIONTECH RESEARCH AND DEVELOPMENT, INC.
To: BIONTECH SE
Reel/Frame 064405/0536 →